期刊文献+

靶向PSCA的缺氧诱导型CAR-T的构建及体外效能研究 被引量:1

Construction and In Vitro Potency Investigation of Hypoxia-Inducible CAR-T Targeting PSCA
原文传递
导出
摘要 该文针对肿瘤微环境中的缺氧环境,利用缺氧相关的启动子,设计和制备在缺氧环境中诱导表达靶向前列腺干细胞抗原(PSCA)的嵌合抗原受体修饰的T细胞(CAR-T),研究缺氧条件下其嵌合抗原受体(CAR)的表达及对肿瘤细胞的体外杀伤作用。研究者通过基因合成缺氧启动子(5H1P)和CAR的DNA片段,利用酶切方法将其插入到慢病毒载体中,然后感染T淋巴细胞。在体外用CoCl2构建缺氧模型,通过流式细胞术检测CoCl2未诱导组CAR有42%的弱阳性表达,诱导后阳性率增加到84.4%,且荧光强度显著增加。结果表明,诱导组比不诱导对照组抗肿瘤效果更好。综上所述,该实验成功构建了靶向PSCA的缺氧诱导型CAR-T,使其在缺氧的环境中效能增强,这为CAR-T在实体瘤的治疗方面提供了新的方案。 Considering anoxic tumor microenvironment,we designed a hypoxia-inducible chimeric antigen receptor-modified T cells(CAR-T)targeting prostate stem cell antigen(PSCA),and tested the cytotoxicity of these cells against tumor cells in vitro.5 H1 P and the sequences encoding the light and heavy chain variable regions of a monoclonal antibody targeting PSCA were synthesized and integrated into lentiviral vectors using restriction enzymes.Then lentivirus were infected to human T lymphocytes isolated from peripheral blood mononuclear cells to preparation CAR-T cells.Taking use of CoCl2,we emulated the hypoxia model in vitro.The positivity rate of PSCA-CAR expression in the T lymphocytes was detected by flow cytometry with or without CoCl2 treatment.There was 42%weak positive subpopulation in uninduced group and increased to 84.4%after CoCl2 induction,in which the fluorescence intensity increased significantly.Cytotoxic assay was performed to evaluate the specific cytotoxicity of the genetically modified T cells against the PSCA-positive HeLa cells,and ELISA was used to detect cytokine secretion by the cells.Results showed that induction group had better cytotoxicity than noninduced control group(P<0.05),and secreted significantly higher levels of cytokines(P<0.01).In conclusion,we successfully constructed the hypoxia-inducible CAR-T targeting PSCA with enhanced potency in anoxic environment.It will provide a new solution for CAR-T treatment in solid tumors.
作者 朱秀秀 王玲 沈俊杰 陈雪娇 钱程 Zhu Xiuxiu;Wang Ling;Shen Junjie;Chen Xuejiao;Qian Cheng(College of Life Science,Zhejiang Sci-Tech University,Hangzhou310018,China;Chongqing Institute of Precision Medicine and Biotechnology Company Limited.,Chongqing400000,China)
出处 《中国细胞生物学学报》 CAS CSCD 2019年第4期636-644,共9页 Chinese Journal of Cell Biology
基金 科技部重点专项(批准号:2016YFC1303400)资助的课题~~
关键词 5H1P CoCl2 缺氧 PSCA CAR-T 抗肿瘤 5H1P CoCl2 hypoxia PSCA CAR-T anti-tumor
  • 相关文献

参考文献2

二级参考文献42

  • 1Brentjens, R., Yeh, R., Bernal, Y., Riviere, I., and Sadelain, M. (2010). Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial. Mol Ther 18, 666-668.
  • 2Brentjens, R.J., Davila, M.L., Riviere, I., Park, J., Wang, X., Cowell, L.G.,I Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., Borquez-OjedaI O., Qu, J., Wasielewska, T., He, Q., Bernal, Y., Rijo, LV., Hedvat, C.I Kobos, R., Curran, K., Steinherz, P., Jurcic, J., Rosenblat, T., MaslakI P., Frattini, M., and Sadelain, M. (2013). CD19-targeted T cells rapidl induce molecular remissions in adults with chemotherapy-refractor acute lymphoblastic leukemia. Sci Transl Med 5, 177ra138. |.
  • 3Brentjens, R.J., Riviere, I., Park, J.H., Davila, M.L., Wang, X., Stefanski, J., Taylor, C., Yeh, R., Bartido, S., Borquez-Ojeda, O., Olszewska, M., Bernal, Y., Pegram, H., Przybylowski, M., Hollyman, D., Usachenko, Y., Pirraglia, D., Hosey, J., Santos, E., Halton, E., Maslak, P., Schein- berg, D., Jurcic, J., Heaney, M., Heller, G., Frattini, M., and Sadelain, M. (2011). Safety and persistence of adoptively transferred autologous CD19-targeted T ceils in patients with relapsed or chemotherapy re- fractory B-cell leukemias. Blood 118, 48174828.
  • 4Brentjens, R.J., Santos, E., Nikhamin, Y., Yeh, R., Matsushita, M., La Perle, K., Quintas-Cardama, A., Larson, S.M., and Sadelain, M. (2007). Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin Cancer Res 13, 5426-5435.
  • 5Carpenito, C., Milone, M.C., Hassan, R., Simonet, J.C., Lakhal, M., Suhoski, M.M., Varela-Rohena, A., Haines, K.M., Heitjan, D.F., A1- belda, S.M., Carroll, R.G., Riley, J.L., Pastan, I., and June, C.H. (2009). Control of large, established tumor xenografts with genetically retar- geted human T ceils containing CD28 and CD137 domains. Proc Natl Acad Sci USA 106, 3360-3365.
  • 6Caserta, S., Alessi, P., Basso, V., and Mondino, A. (2010). IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4+ T cells. Eur J Immuno140, 470-479.
  • 7Cruz, C.R., Micklethwaite, K.P., Savoldo, B., Ramos, C.A., Lam, S., Ku, S., Diouf, O., Liu, E., Barrett, A.J., Ito, S., Shpall, E.J., Krance, R.A., Kamble, R.T., Carrum, G., Hosing, C.M., Gee, A.P., Mei, Z., Grilley, B.J., Heslop, H.E., Rooney, C.M., Brenner, M.K., Bollard, C.M., and Dotti, G. (2013). Infusion of donor-derived CD19-redirected vi- rus-specific T ceils for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood 122, 2965-2973.
  • 8Cui, Y., Zhang, H, Meadors, J., Poon,-R., Guimond, M., and Mackall, C.L. (2009). Harnessing the physiology of lymphopenia to support adoptiv immunotherapy in lymphoreplete hosts. Blood 114, 3831-3840. |.
  • 9Curran, K.J., Seinstra,'B.)k., Nikhamin, Y., Yeh, R., Usachenko, Y., van Leeuwen, D.G., Purdon, T., Pegram, H.J., and Brentjens, R.J. (2015). Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression. Mol Ther 23,769-778.
  • 10Davila, II.L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S.S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., Qu, J., Wasielewska, T., He, Q., Fink, M., Shinglot, H., Youssif, M., Satter, M., Wang, Y., Hosey, J., Quintanilla, H., Halton, E., Bernal, Y., Bou- hassira, D.C., Arcila, M.E., Gonen, M., Roboz, G.J., Maslak, P., Douer, D., Frattini, M.G., Giralt, S., Sadelain, M., and Brentjens, R. (2014). Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Meal 6, 224ra225.

共引文献12

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部